🔗 Share this article

The top legal official in Texas Paxton is suing the manufacturers of Tylenol, claiming the firms hid alleged dangers that the pain reliever posed to children's cognitive development.

The lawsuit arrives four weeks after Donald Trump promoted an unproven link between consuming acetaminophen - alternatively called paracetamol - while pregnant and autism in young ones.

Paxton is taking legal action against the pharmaceutical giant, which once produced the medication, the only pain reliever recommended for pregnant women, and the current manufacturer, which currently produces it.

In a declaration, he stated they "betrayed America by profiting off of discomfort and marketing drugs without regard for the potential hazards."

The company asserts there is lacking scientific proof connecting acetaminophen to autism.

"These corporations lied for decades, knowingly endangering millions to increase profits," the attorney general, from the Republican party, declared.

Kenvue said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the safety of acetaminophen and the possible consequences that could have on the welfare of American women and children."

On its online platform, the company also stated it had "regularly reviewed the applicable studies and there is lacking reliable evidence that demonstrates a established connection between using paracetamol and autism."

Organizations representing doctors and healthcare providers share this view.

The American College of Obstetricians and Gynecologists has said paracetamol - the primary component in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can pose serious health risks if left untreated.

"In over twenty years of studies on the consumption of acetaminophen in pregnancy, no reliable research has successfully concluded that the usage of paracetamol in any period of pregnancy causes neurological conditions in young ones," the group said.

The court filing cites current declarations from the previous government in asserting the medication is allegedly unsafe.

Recently, the former president raised alarms from public health officials when he told expectant mothers to "struggle intensely" not to take acetaminophen when ill.

The US Food and Drug Administration then published an announcement that doctors should contemplate reducing the consumption of acetaminophen, while also mentioning that "a causal relationship" between the drug and autism spectrum disorder in minors has remains unverified.

The Health Department head Kennedy, who supervises the FDA, had promised in spring to initiate "extensive scientific investigation" that would determine the origin of autism spectrum disorder in a limited time.

But authorities advised that finding a unique factor of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and environmental factors - would not be simple.

Autism is a type of lifelong neurodivergence and condition that influences how people perceive and engage with the environment, and is identified using physician assessments.

In his court filing, Paxton - a Trump ally who is campaigning for federal office - asserts Kenvue and J&J "deliberately disregarded and sought to suppress the research" around acetaminophen and autism spectrum disorder.

This legal action attempts to require the companies "eliminate any commercial messaging" that asserts acetaminophen is secure for women during pregnancy.

The court case mirrors the concerns of a assembly of parents of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in 2022.

A federal judge dismissed the lawsuit, stating studies from the plaintiffs' authorities was inconclusive.